Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Paranta Biosciences

Paranta Biosciences?uq=w9if130k
2011 FOUNDED
PRIVATE STATUS
Angel LATEST DEAL TYPE
$7M LATEST DEAL AMOUNT
1 INVESTORS
Description

Operator of a clinical stage bio-pharmaceutical company in Australia. The company operates a therapeutic platform for the treatment of fibrotic and inflammatory diseases.

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Primary Office
  • Suite 549
  • 1 Queens Road
  • Melbourne, Victoria 3004
  • Australia

+61 (03) 0000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Paranta Biosciences’s full profile, request a free trial.

Paranta Biosciences Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Angel (individual) 01-Oct-2015 $7M 0000 Completed Startup
3. Grant 01-Jan-2015 00000 000 Completed Startup
2. Angel (individual) 01-Jul-2014 $3M $9M Completed Startup
1. Angel (individual) $6M $6M Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Paranta Biosciences Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
BioPharmaceuticals Australia Government 000 0000 000000 0

Paranta Biosciences Executive Team (2)

Name Title Board
Seat
Contact
Info
Ross Barrow Chief Executive Officer & Director
David de Kretser MD Chief Scientist & Board Member

Paranta Biosciences Board Members (4)

Name Representing Role Since Contact
Info
Austin S.E. Miller Paranta Biosciences Board Member 000 0000
David de Kretser MD Paranta Biosciences Chief Scientist & Board Member 000 0000
John Raff Ph.D Paranta Biosciences Board Member 000 0000
Peter Hodgson Self Chairman 000 0000